• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

倾斜试验阳性的晕厥患者晕厥复发的危险因素。

Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope.

作者信息

Sheldon R, Rose S, Flanagan P, Koshman M L, Killam S

机构信息

Cardiovascular Research Group, University of Calgary, Alberta, Canada.

出版信息

Circulation. 1996 Mar 1;93(5):973-81. doi: 10.1161/01.cir.93.5.973.

DOI:10.1161/01.cir.93.5.973
PMID:8598089
Abstract

BACKGROUND

Recent work with head-up tilt-table testing has suggested that many patients with syncope may have recurrent neurally mediated episodes of bradycardia, hypotension, or both. The purpose of this study was to determine how to identify patients at high risk of a recurrence of neuromediated syncope after a positive isoproterenol/tilt-table test.

METHODS AND RESULTS

A cohort of 101 drug-free patients in a university hospital outpatient clinic with syncope and a positive isoproterenol/tilt-table test underwent baseline assessment of demographic variables, symptomatic burden, and hemodynamic and clinical responses to tilt testing. The primary outcome measure was the time to the first recurrent syncopal spell. The actuarial probabilities of remaining syncope free after 1 and 2 years were 72% and 60%, respectively. Multivariate proportional hazards analysis demonstrated that the most powerful predictor of a recurrence of syncope was the logarithm of the number of preceding syncopal spells (P<.001). Other predictive variables included the duration of syncopal symptoms, tilt test symptomatic outcome, and trough heart rate. The probability of a recurrence of syncope also varied with the logarithm of the frequency of preceding spells (P=.008). The median frequency of pretest spells was 0.3/month; after the tilt test, the median frequency dropped approximately 90% to 0.03 per month.

CONCLUSIONS

The risk of a recurrence of syncope after a positive tilt-table test can be predicted with simple pretest and intratest variables.

摘要

背景

近期有关头高位倾斜试验的研究表明,许多晕厥患者可能会反复出现神经介导的心动过缓、低血压或两者兼有的情况。本研究的目的是确定如何识别在异丙肾上腺素/倾斜试验阳性后有神经介导性晕厥复发高风险的患者。

方法与结果

在一所大学医院门诊,对101例无药物治疗的晕厥患者且异丙肾上腺素/倾斜试验阳性者进行了人口统计学变量、症状负担以及倾斜试验的血流动力学和临床反应的基线评估。主要结局指标是首次复发性晕厥发作的时间。1年和2年后无晕厥的精算概率分别为72%和60%。多变量比例风险分析表明,晕厥复发的最有力预测因素是既往晕厥发作次数的对数(P<0.001)。其他预测变量包括晕厥症状持续时间、倾斜试验症状结局和最低心率。晕厥复发的概率也随既往发作频率的对数而变化(P=0.008)。试验前发作的中位频率为每月0.3次;倾斜试验后,中位频率下降约90%至每月0.03次。

结论

通过简单的试验前和试验中变量可以预测倾斜试验阳性后晕厥复发的风险。

相似文献

1
Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope.倾斜试验阳性的晕厥患者晕厥复发的危险因素。
Circulation. 1996 Mar 1;93(5):973-81. doi: 10.1161/01.cir.93.5.973.
2
Timing of first recurrence of syncope predicts syncopal frequency after a positive tilt table test result.倾斜试验结果呈阳性后,晕厥首次复发的时间可预测晕厥频率。
J Am Coll Cardiol. 1997 May;29(6):1284-9. doi: 10.1016/s0735-1097(97)00047-8.
3
Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test.
Am J Cardiol. 1996 Sep 1;78(5):536-9. doi: 10.1016/s0002-9149(96)00359-1.
4
Long-term follow-up of children and adolescents with syncope; predictor of syncope recurrence.晕厥儿童和青少年的长期随访;晕厥复发的预测因素。
Eur Heart J. 2001 Sep;22(17):1618-25. doi: 10.1053/euhj.2000.2577.
5
Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome.无结构性心脏病证据的年轻竞技运动员运动相关晕厥。临床表现及长期预后。
Eur Heart J. 2002 Jul;23(14):1125-30. doi: 10.1053/euhj.2001.3042.
6
Comparison of patients with syncope of unknown cause having negative or positive tilt-table tests.
Am J Cardiol. 1997 Sep 1;80(5):581-5. doi: 10.1016/s0002-9149(97)00425-6.
7
Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation.患者特征对延长基线头高位倾斜试验阳性率及药物激发试验额外阳性率的影响。
Heart. 1996 Nov;76(5):406-11. doi: 10.1136/hrt.76.5.406.
8
Head-up tilt test in patients with high pretest likelihood of neurally mediated syncope: an approximation to the "real sensitivity" of this testing.对神经介导性晕厥预测试验可能性高的患者进行头高位倾斜试验:该试验“真实敏感性”的一种近似情况。
Pacing Clin Electrophysiol. 1999 Aug;22(8):1173-8. doi: 10.1111/j.1540-8159.1999.tb00597.x.
9
Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management.老年人反复不明原因晕厥:头直立倾斜试验在评估和管理中的应用
J Am Geriatr Soc. 1992 Nov;40(11):1123-8. doi: 10.1111/j.1532-5415.1992.tb01801.x.
10
Tilt table testing in the evaluation and management of athletes with recurrent exercise-induced syncope.
Med Sci Sports Exerc. 1993 Jan;25(1):24-8. doi: 10.1249/00005768-199301000-00005.

引用本文的文献

1
A contemporary review of the head-up tilt test: Utility and limitations.头高位倾斜试验的当代综述:效用与局限性
Indian Heart J. 2025 May-Jun;77(3):243-251. doi: 10.1016/j.ihj.2025.03.014. Epub 2025 Apr 2.
2
Counter pressure maneuvers for syncope prevention: A semi-systematic review and meta-analysis.预防晕厥的对抗压力手法:一项半系统综述与荟萃分析。
Front Cardiovasc Med. 2022 Oct 13;9:1016420. doi: 10.3389/fcvm.2022.1016420. eCollection 2022.
3
Age Is a Predictor for the Syncope Recurrence in Elderly Vasovagal Syncope Patients With a Positive Head-Up Tilt Test.
年龄是倾斜试验阳性的老年血管迷走性晕厥患者晕厥复发的一个预测因素。
Front Cardiovasc Med. 2021 Jun 29;8:667171. doi: 10.3389/fcvm.2021.667171. eCollection 2021.
4
Economic value of insertable cardiac monitors in unexplained syncope in the United States.美国不明原因晕厥中植入式心脏监测器的经济价值。
Open Heart. 2021 Feb;8(1). doi: 10.1136/openhrt-2020-001263.
5
Syncope in a Working-Age Population: Recurrence Risk and Related Risk Factors.工作年龄人群中的晕厥:复发风险及相关危险因素
J Clin Med. 2019 Jan 29;8(2):150. doi: 10.3390/jcm8020150.
6
Heart rate recovery and diastolic blood pressure ratio on the treadmill test predict an induction and recurrence of vasovagal syncope.在跑步机测试中,心率恢复和舒张压比值可预测血管迷走性晕厥的诱发和复发。
Korean J Intern Med. 2019 Mar;34(2):315-323. doi: 10.3904/kjim.2017.180. Epub 2017 Dec 18.
7
Renal nerve stimulation for treatment of neurocardiogenic syncope: a review from perspective of commercialization potential.肾神经刺激治疗神经心源性晕厥:从商业化潜力角度的综述
Ir J Med Sci. 2018 Feb;187(1):45-54. doi: 10.1007/s11845-017-1643-7. Epub 2017 Jun 14.
8
Syncope as a health risk for soldiers - influence of medical history and clinical findings on the sensitivity of head-up tilt table testing.晕厥对士兵的健康风险——病史和临床发现对直立倾斜试验敏感性的影响。
Mil Med Res. 2015 Dec 2;2:31. doi: 10.1186/s40779-015-0062-1. eCollection 2015.
9
Ongoing clinical trials for Vasovagal Syncope: where are we in 2014?血管迷走性晕厥的正在进行的临床试验:2014年我们处于什么阶段?
Auton Neurosci. 2014 Sep;184:77-82. doi: 10.1016/j.autneu.2014.05.009. Epub 2014 May 27.
10
Near-infrared diffuse optical monitoring of cerebral blood flow and oxygenation for the prediction of vasovagal syncope.用于预测血管迷走性晕厥的脑血流和氧合的近红外漫射光学监测
J Biomed Opt. 2014 Jan;19(1):17001. doi: 10.1117/1.JBO.19.1.017001.